Open Heart

AUGUST 25, 2024

Background On the one hand, the primary coronary slow flow phenomenon (CSFP) can cause recurrence of chest pain, prompting medical examinations and further healthcare costs, while on the other hand, it can lead to myocardial infarction, ventricular arrhythmia and sudden cardiac death.

Sudden Cardiac Death 40

Sudden Cardiac Death Angina Chest Pain Myocardial Infarction 40

DAIC

APRIL 9, 2024

It causes the heart muscle to become stiff and thick, making it harder for the heart to pump blood properly and increasing the risk of sudden cardiac death. HCM is the most common genetic heart disease worldwide and is estimated to affect 1 in 500 people.

Cardiomyopathy 52

Cardiomyopathy Quality of Life Chest Pain Preserved Ejection Fraction 52

DAIC

JANUARY 23, 2024

21-23 hsCRP is nonspecific inflammatory marker and an acute phase reactant that predicts the likelihood of a heart attack, stroke, peripheral artery disease and sudden cardiac death among healthy individuals with no history of CV disease, and recurrent events and death in patients with known ASCVD.22

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Dr. Anish Koka

JANUARY 18, 2023

🤨 20% reduction in traditional MACE (CV death, MI, stroke) 4:49 AM ∙ Jan 14, 2023 13 Likes 2 Retweets But the primary endpoint here was a composite endpoint of cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, or coronary revascularization.

Document 52

Document Academic Heart Attack Heart attacks 52

Dr. S. Venkatesan MD

AUGUST 19, 2024

There is a problem here too ,even critical Ischemia with high grade unstable angina rarely trigger a VT but STEMI seems to have the exclusive rights to trigger it , by its ability to produce acute transmural ischemia. Even here, it is the associated factors, like hypoxia or acidosis are the triggers which of course are resultant of Ischemia.

Ischemia 52

Ischemia Sudden Cardiac Death Ablation Arrhythmia 52

Frontiers in Cardiovascular Medicine

JANUARY 6, 2025

Evidence supports the use of TXL plus WM for reducing angina frequency [SMD 2.50, 95% CI (3.53, 1.48)], improving seattle angina questionnaire scores (P<0.05), decreasing nitroglycerin dose [SMD 1.63, 95% CI (2.26, 1.00)], and shortening angina duration [MD 1.50min/once, 95% CI (1.98, 1.02)].

Sudden Cardiac Death 52

Sudden Cardiac Death Angina Myocardial Infarction 52

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

BackgroundAnomalous aortic origin of a coronary artery (AAOCA) is associated with an increased risk of myocardial ischemia and sudden cardiac death. The incidence of postoperative cardiac-type symptoms (angina, syncope or dyspnea) was higher in ALCA-R patients compared to ARCA-L patients.

Aortic 52

Aortic Sudden Cardiac Death Angioplasty Outcomes 52